Long-term Antipsychotic Treatment and Brain Volumes: A Longitudinal Study of First-Episode Schizophrenia
TLDR
It is suggested that antipsychotics have a subtle but measurable influence on brain tissue loss over time, suggesting the importance of careful risk-benefit review of dosage and duration of treatment as well as their off-label use.Abstract:
Context Progressive brain volume changes in schizophrenia are thought to be due principally to the disease. However, recent animal studies indicate that antipsychotics, the mainstay of treatment for schizophrenia patients, may also contribute to brain tissue volume decrement. Because antipsychotics are prescribed for long periods for schizophrenia patients and have increasingly widespread use in other psychiatric disorders, it is imperative to determine their long-term effects on the human brain. Objective To evaluate relative contributions of 4 potential predictors (illness duration, antipsychotic treatment, illness severity, and substance abuse) of brain volume change. Design Predictors of brain volume changes were assessed prospectively based on multiple informants. Setting Data from the Iowa Longitudinal Study. Patients Two hundred eleven patients with schizophrenia who underwent repeated neuroimaging beginning soon after illness onset, yielding a total of 674 high-resolution magnetic resonance scans. On average, each patient had 3 scans (≥2 and as many as 5) over 7.2 years (up to 14 years). Main Outcome Measure Brain volumes. Results During longitudinal follow-up, antipsychotic treatment reflected national prescribing practices in 1991 through 2009. Longer follow-up correlated with smaller brain tissue volumes and larger cerebrospinal fluid volumes. Greater intensity of antipsychotic treatment was associated with indicators of generalized and specific brain tissue reduction after controlling for effects of the other 3 predictors. More antipsychotic treatment was associated with smaller gray matter volumes. Progressive decrement in white matter volume was most evident among patients who received more antipsychotic treatment. Illness severity had relatively modest correlations with tissue volume reduction, and alcohol/illicit drug misuse had no significant associations when effects of the other variables were adjusted. Conclusions Viewed together with data from animal studies, our study suggests that antipsychotics have a subtle but measurable influence on brain tissue loss over time, suggesting the importance of careful risk-benefit review of dosage and duration of treatment as well as their off-label use.read more
Citations
More filters
Book ChapterDOI
Neuroimaging and the Longitudinal Course of Schizophrenia
TL;DR: Overall, the available MRI data indicate that structural brain abnormalities associated with the diagnosis of schizophrenia may progress from the first psychotic episode to chronic disease states, particularly during the initial few years after illness onset.
Journal ArticleDOI
Increased subcortical region volume induced by electroconvulsive therapy in patients with schizophrenia.
Xiaoxiao Shan,Haisan Zhang,Zhao Dong,Jindong Chen,Feng Liu,Jingping Zhao,Hongxing Zhang,Wenbin Guo +7 more
TL;DR: In this article, the treatment effects of ECT on brain structure in patients with schizophrenia were explored using structural magnetic resonance imaging (SMI) and Voxel-based morphometry was applied to analyze the imaging data.
Journal ArticleDOI
Proteomics and Neurodegenerative Disorders: Advancements in the Diagnostic Analysis.
TL;DR: Changes in protein structure and function, alteration in protein-protein interaction, and significant difference in protein concentration inside the body could play an important role in indicating the pathological evidence of abnormalities before the development of clinical symptoms and act as a critical detection and diagnostic tool commonly known as biomarkers.
Journal ArticleDOI
Successful management of clozapine adverse effects with extended (alternate day) antipsychotic dosing in a patient with schizophrenia.
TL;DR: A 57-year-old woman with treatment-resistant schizophrenia was started on clozapine as augmentation to her ongoing treatment with olanzapine (15 mg/d), and remained largely asymptomatic on the new regimen without any adverse effects of medications.
Journal ArticleDOI
Cortical morphology and illness insight in patients with schizophrenia.
Marie-Luise Otte,Mike M. Schmitgen,Katharina M. Kubera,Nadine D. Wolf,Stefan Fritze,Lena S. Geiger,Heike Tost,Ulrich Seidl,Andreas Meyer-Lindenberg,Dusan Hirjak,Robert Christian Wolf +10 more
TL;DR: In this article, the authors examined associations between illness insight and two cortical surface markers that are known to follow distinct neurodevelopmental trajectories, i.e. cortical gyrification (CG) and thickness (CT).
References
More filters
Book
The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020.
TL;DR: This is the first in a planned series of 10 volumes that will attempt to "summarize epidemiological knowledge about all major conditions and most risk factors" and use historical trends in main determinants to project mortality and disease burden forward to 2020.
Journal ArticleDOI
The Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbance.
TL;DR: The relative simplicity, reliability, and validity of the GAS suggests that it would be useful in a wide variety of clinical and research settings.
Journal ArticleDOI
Mapping cortical change across the human life span
Elizabeth R. Sowell,Bradley S. Peterson,Paul M. Thompson,Suzanne E. Welcome,Amy L. Henkenius,Arthur W. Toga +5 more
TL;DR: A significant, nonlinear decline in GMD with age is found over dorsal frontal and parietal association cortices on both the lateral and interhemispheric surfaces, indicating that the posterior temporal cortices have a more protracted course of maturation than any other cortical region.
Journal ArticleDOI
The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.
TL;DR: Research strategies suggest that investigators should maintain a flexible database to permit them to adapt to changes in diagnostic systems, to do comparative nosological studies, and, ultimately, to develop new diagnostic systems based on knowledge concerning the underlying neurobiological nature of disorders.
Journal ArticleDOI
Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17.
TL;DR: Abnormally high density in the cerebral cortices of schizophrenics suggests that neuronal atrophy is the anatomic substrate for deficient information processing in schizophrenia.